Publication | Open Access
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
35
Citations
48
References
2020
Year
CSF sTREM2 levels were associated with clinical progression in AD, regardless of core biomarkers. This could be useful in assessing disease development in relation to patient care and clinical trial recruitment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1